Tumor Reduction in Primary and Metastatic Pancreatic Cancer Lesions With nab-Paclitaxel and Gemcitabine: An Exploratory Analysis From a Phase 3 Study.
about
Is Pancreatic Head Cancer with Portal Venous Involvement Really Borderline Resectable? Appraisal of an Upfront Surgery Series.Nano albumin bound-paclitaxel in pancreatic cancer: Current evidences and future directionsA successful case of locally advanced pancreatic cancer undergoing curative distal pancreatectomy with en bloc celiac axis resection after combination chemotherapy of nab-paclitaxel with gemcitabine.Response assessment in pancreatic ductal adenocarcinoma: role of imaging.
P2860
Tumor Reduction in Primary and Metastatic Pancreatic Cancer Lesions With nab-Paclitaxel and Gemcitabine: An Exploratory Analysis From a Phase 3 Study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Tumor Reduction in Primary and ...... Analysis From a Phase 3 Study.
@en
Tumor Reduction in Primary and ...... Analysis From a Phase 3 Study.
@nl
type
label
Tumor Reduction in Primary and ...... Analysis From a Phase 3 Study.
@en
Tumor Reduction in Primary and ...... Analysis From a Phase 3 Study.
@nl
prefLabel
Tumor Reduction in Primary and ...... Analysis From a Phase 3 Study.
@en
Tumor Reduction in Primary and ...... Analysis From a Phase 3 Study.
@nl
P2093
P2860
P1433
P1476
Tumor Reduction in Primary and ...... Analysis From a Phase 3 Study.
@en
P2093
Daniel D Von Hoff
David Goldstein
Markus F Renschler
Ramesh K Ramanathan
Stefano Ferrara
Volker Kunzmann
P2860
P304
P356
10.1097/MPA.0000000000000742
P577
2016-11-10T00:00:00Z